Vivos (RDGL) EBIT Growth (5y) (2015 - 2025)
Vivos (RDGL) EBIT Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.99% |
| Sep 30, 2025 | -32.83% |
| Jun 30, 2025 | -39.34% |
| Mar 31, 2025 | -48.30% |
| Dec 31, 2024 | -15.32% |
| Sep 30, 2024 | -6.79% |
| Jun 30, 2024 | -24.73% |
| Mar 31, 2024 | -20.71% |
| Dec 31, 2023 | 11.37% |
| Sep 30, 2023 | -38.10% |
| Jun 30, 2023 | -21.74% |
| Mar 31, 2023 | 2.83% |
| Dec 31, 2022 | -1.01% |
| Sep 30, 2022 | 22.04% |
| Jun 30, 2022 | -4.93% |
| Mar 31, 2022 | -15.43% |
| Dec 31, 2021 | -29.65% |
| Sep 30, 2021 | 21.82% |
| Jun 30, 2021 | 10.45% |
| Mar 31, 2021 | 19.20% |